Acerus Pharmaceuticals Corporation carries a market capitalization of 2.77M, placing it among publicly traded companies globally.
| Market Cap | 2.77M |
| Enterprise Value | N/A |
Acerus Pharmaceuticals Corporation's stock has declined approximately -95.5% over the past 52 weeks. The 50-day moving average sits at 0.52, while the 200-day moving average is 2.08.
| Beta (5Y) | N/A |
| 52-Week Price Change | -95.5% |
| 50-Day Moving Average | 0.52 |
| 200-Day Moving Average | 2.08 |
| Average Volume (20 Days) | N/A |
Acerus Pharmaceuticals Corporation's most recent stock split took place on April 29, 2022 with a 200:1 split ratio.
| Last Split Date | 4/29/2022 |
| Split Ratio | 200:1 |